Ypsomed Patents – Key Insights and Stats

Ypsomed has a total of 2162 patents globally, out of which 1029 have been granted. Of these 2162 patents, more than 32% patents are active. The United States of America is where Ypsomed has filed the maximum number of patents, followed by Europe and Germany. Parallelly, Germany seems to be the main focused R&D center and also Switzerland is the origin country of Ypsomed Holding.

Ypsomed was founded in 2003. Ypsomed operates as a holding company. The Company, through its subsidiaries, develops and manufactures custom-made injection systems for pharmaceutical and bio-technology companies. As of September 2022, Ypsomed has a market cap of $2 Billion.

Do read about some of the most popular patents of Ypsomed which have been covered by us in this article and also you can find Ypsomed patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Ypsomed patent portfolio.

How many patents does the Founder and CEO of Ypsomed have?

The Founder Willy Michel has 18 patents and the CEO Simon Michel have 29 patents.

How many patents does Ypsomed have?

Ypsomed has a total of 2162 patents globally. These patents belong to 482 unique patent families. Out of 2162 patents, 708 patents are active.

How Many Patents did Ypsomed File Every Year?

Ypsomed Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantYpsomed Applications FiledYpsomed Patents Granted
20111952
20122747
20136655
20144423
20155023
20166624
20176532
20187630
201910268
20208556
20214640
2022630

How many Ypsomed patents are Alive/Dead?

Worldwide Patents

Ypsomed Patents Portfolio

How Many Patents did Ypsomed File in Different Countries?

Ypsomed Worldwide Patents

Countries in which Ypsomed Filed Patents

CountryPatents
United States Of America381
Europe334
Germany283
China163
Japan163
Switzerland99
Australia93
Austria68
Denmark62
Poland40
India26
Spain15
Canada15
Israel13
Mexico11
United Kingdom10
Hong Kong (S.A.R.)9
Brazil9
Korea (South)9
Hungary7
Russia6
Taiwan6
South Africa6
Portugal5
Croatia5
Philippines4
Czech Republic2

Where are Research Centers of Ypsomed Patents Located?

Research Centers of Ypsomed Patents

10 Best Ypsomed Patents

US7056302B2 is the most popular patent in the Ypsomed portfolio. It has received 610 citations so far from companies like Abbott, Unomedica and Dexcom, Inc.

Below is the list of 10 most cited patents of Ypsomed Holding:

Publication NumberCitation Count
US7056302B2610
US20060153693A1473
WO2005004955A1434
US6629949B1341
US6685674B2306
US6659982B2257
US20060189938A1209
US6641566B2200
US20070027430A1198
USD472316S1193

Which Companies are using Ypsomed Patents to Advance their Research?

If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.

The top citing companies in the Ypsomed patent portfolio are Sanofi, Becton Dickinson and Shl Medical.

List of the top forward citing Companies –

CompanyNumber of Patents
Sanofi145
Becton Dickinson35
Shl Medical Ag27
Novo Nordisk As22
Owen Mumford11
Medtronic Minimed Inc11
Unomedical9
Norton Healthcare Limited8
Tecpharma Licensing Ag8
Kaleo Inc6

Count of 102 and 103 Type Rejections based on Ypsomed Patents

Top Ypsomed Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US20060153693A116
US7955303B213
US6685674B212
US8052653B212
US20070021718A112
US7309326B212
US8409145B211
US8992487B210
US7374558B210
US7749186B29
US7445613B29
US7931615B28
US7811263B28
US7125395B28
US7118553B27

What Percentage of Ypsomed US Patent Applications were Granted?

Ypsomed (Excluding its subsidiaries) has filed 177 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 132 have been granted leading to a grant rate of 98.5%.

Below are the key stats of Ypsomed patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Ypsomed Holding?

Law FirmTotal ApplicationsSuccess Rate
Dorsey & Whitney Llp15798.23%
Knobbe Martens Olson & Bear Llp15100.00%
David E Bruhn Esq3100.00%
Hamre Schumann Mueller & Larson Pc1100.00%
T Gene Dillahunty1100.00%

What are Ypsomed Holding key innovation segments?

What Technologies are Covered by Ypsomed Holding?

The chart below distributes patents filed by Ypsomed Holding in different countries on the basis of the technology protected in patents. It also represents the markets where Ypsomed Holding thinks it’s important to protect particular technology inventions.

R&D Focus: How has Ypsomed Holding search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Ypsomed Holding?

Related Articles

Medinol Patents – Insights & Stats (Updated 2023)

Medinol has a total of 919 patents globally, out of which 1568 have been granted. Of these 919 patents, more than 16% patents are active. United States of America is where Medinol has filed the maximum number of patents, followed by Europe (EPO) and Germany. Parallelly, United States of America

Read More »

Creo Medical Patents – Insights & Stats (Updated 2023)

Creo Medical has a total of 2132 patents globally, out of which 813 have been granted. Of these 2132 patents, more than 85% patents are active. United Kingdom is where Creo Medical has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, United Kingdom seems to

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.